LONDON (Alliance News) - Omega Diagnostics Group PLC said on Thursday it has CE-marked another five allergens.
Omega also confirmed that commercialisation activities with Immunodiagnostic Systems Holdings PLC are proceeding to plan, and that it has received its first purchase order which it will supply by the end of October.
"The size of the order is in line with the company's expectation, whereby sales are expected to be modest during the initial launch phase," Omega commented.
Omega's recent CE-marking has extended the menu to 58 allergens which can be run on the fully automated Immunodiagnostic Systems instrument.
These allergens will be supplied to Immunodiagnostic Systems under the global distribution agreement announced in April this year.
Shares in Omega were up 2.2% at 15.22 pence on Thursday. Immunodiagnostic Systems was untraded at 230.0p.